Depression and diabetes: Establishing the pharmacist's role in detecting comorbidity in pregnant women

Journal of the American Pharmacists Association

Volumn 50, Issue 2, 2010, Pages 195-199

  Ragland, Denise ^a   Payakachat, Nalin ^a   Hays, Erin Beth ^b   Banken, Joseph ^c   Dajani, Nafisa K ^c   Ott, Rachel E ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b White River Medical Center   (United States)

^c UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Comorbidities; Depression; Diabetes; Pharmacists; Pregnancy; Screening program

Indexed keywords

ANTIDEPRESSANT AGENT;

ADULT; ARTICLE; COMORBIDITY; CROSS-SECTIONAL STUDY; DEPRESSION; FEMALE; HUMAN; METHODOLOGY; PATIENT EDUCATION; PHARMACIST; PILOT STUDY; PREGNANCY; PREGNANCY DIABETES MELLITUS; PRENATAL CARE; PREVALENCE; PROFESSIONAL STANDARD; PSYCHOLOGICAL ASPECT; STANDARD; UNITED STATES;

ADULT; ANTIDEPRESSIVE AGENTS; ARKANSAS; COMORBIDITY; CROSS-SECTIONAL STUDIES; DEPRESSION; DIABETES, GESTATIONAL; FEMALE; HUMANS; PATIENT EDUCATION AS TOPIC; PHARMACISTS; PILOT PROJECTS; PREGNANCY; PREGNANCY IN DIABETICS; PRENATAL CARE; PREVALENCE; PROFESSIONAL ROLE;

EID: 77952469135     PISSN: 15443191     EISSN: 15443450     Source Type: Journal    
DOI: 10.1331/JAPhA.2010.09191     Document Type: Article

References (14)

1. American Diabetes Association. Economic costs of diabetes in the U.S. in 2007. Diabetes Care. 2008;31:596-615.
2. Anderson RJ, Freedland KE, Clouse RE, Lustman P. The prevalence of comorbid depression in adults with diabetes: a metaanalysis. Diabetes Care. 2001;24:1069-78.
3. Lustman PJ, Williams MM, Sayuk GS, et al. Factors influencing glycemic control in type 2 diabetes during acute- and maintenance-phase treatment of major depressive disorder with bupropion. Diabetes Care. 2007;30:459-66.
4. Bennett HA, Einarson A, Taddio A, et al. Prevalence of depression during pregnancy: systematic review. Obstet Gynecol. 2004;103:698-709.
5. Gaynes BN, Gavin N, Meltzer-Brody S, et al. Perinatal depression: prevalence, screening accuracy and screening outcomes. Evid Rep Technol Assess (Summ). 2005 Feb;(119):1-8.
6. Parry BL, Newton RP. Chronological basis of female-specific mood disorders. Neuropsychopharmacology. 2001;25(5 suppl):S192-8.
7. Wisner KL, Gelenberg AJ, Leonard H, et al. Pharmalogic treatment of depression during pregnancy. JAMA. 1999;282:1264-9.
8. Robert E. Treating depression during pregnancy. N Engl J Med. 1996;335:1056-8.
9. Nonacs R, Cohen LS. Depression during pregnancy: diagnosis and treatment options. J Clin Psychiatry. 2002;63:24-30.
10. Burt VK, Stein K. Epidemiology of depression throughout the female life cycle. J Clin Psychiatry. 2002;63:9-15.
11. Beck AT, Steer RA, Brown GK. Manual for the Beck Depression Inventory-II. San Antonio, TX: Psychological Corporation; 1996.
12. Cox JL, Holden JM, Sagovsky R. Detection of postnatal depression: development of the 10-item Edinburgh Postnatal Depression Scale. Br J Psychiatry. 1987;1500:782-6.
13. Yonkers KA, Wisner KL, Stewart DE, et al. The management of depression during pregnancy: a report from the American Psychiatric Association and the American College of Obstetricians and Gynecologists. Obstet Gynecol. 2009;114:703-13.
14. Gonzalez JS, Safren SA, Cagliero E, et al. Depression, self-care, and medication adherence in type 2 diabetes. Diabetes Care. 2007;30:2222-7.